Rockwell Medical Debt to Equity Ratio 2012-2025 | RMTI
Current and historical debt to equity ratio values for Rockwell Medical (RMTI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Rockwell Medical debt/equity for the three months ending September 30, 2025 was 0.25.
| Rockwell Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.02B | $0.04B | 0.55 |
| 2025-06-30 | $0.02B | $0.03B | 0.73 |
| 2025-03-31 | $0.02B | $0.03B | 0.71 |
| 2024-12-31 | $0.03B | $0.03B | 0.82 |
| 2024-09-30 | $0.03B | $0.03B | 0.96 |
| 2024-06-30 | $0.03B | $0.02B | 1.26 |
| 2024-03-31 | $0.03B | $0.02B | 1.46 |
| 2023-12-31 | $0.03B | $0.02B | 1.45 |
| 2023-09-30 | $0.03B | $0.02B | 1.45 |
| 2023-06-30 | $0.03B | $0.01B | 2.99 |
| 2023-03-31 | $0.03B | $0.01B | 2.23 |
| 2022-12-31 | $0.03B | $0.01B | 2.31 |
| 2022-09-30 | $0.04B | $0.02B | 2.36 |
| 2022-06-30 | $0.04B | $0.02B | 1.94 |
| 2022-03-31 | $0.04B | $-0.01B | -8.79 |
| 2021-12-31 | $0.05B | $0.00B | 18.16 |
| 2021-09-30 | $0.05B | $0.01B | 4.29 |
| 2021-06-30 | $0.05B | $0.02B | 2.50 |
| 2021-03-31 | $0.04B | $0.03B | 1.65 |
| 2020-12-31 | $0.04B | $0.03B | 1.28 |
| 2020-09-30 | $0.04B | $0.04B | 1.03 |
| 2020-06-30 | $0.04B | $0.02B | 2.61 |
| 2020-03-31 | $0.05B | $0.02B | 2.07 |
| 2019-12-31 | $0.02B | $0.02B | 1.18 |
| 2019-09-30 | $0.02B | $0.02B | 1.03 |
| 2019-06-30 | $0.03B | $0.03B | 0.93 |
| 2019-03-31 | $0.03B | $0.02B | 1.42 |
| 2018-12-31 | $0.03B | $0.03B | 0.93 |
| 2018-09-30 | $0.03B | $0.01B | 2.01 |
| 2018-06-30 | $0.03B | $0.02B | 1.45 |
| 2018-03-31 | $0.03B | $0.03B | 0.90 |
| 2017-12-31 | $0.03B | $0.03B | 0.79 |
| 2017-09-30 | $0.03B | $0.04B | 0.61 |
| 2017-06-30 | $0.03B | $0.04B | 0.59 |
| 2017-03-31 | $0.03B | $0.05B | 0.59 |
| 2016-12-31 | $0.03B | $0.05B | 0.57 |
| 2016-09-30 | $0.03B | $0.06B | 0.49 |
| 2016-06-30 | $0.03B | $0.06B | 0.51 |
| 2016-03-31 | $0.03B | $0.06B | 0.48 |
| 2015-12-31 | $0.03B | $0.06B | 0.41 |
| 2015-09-30 | $0.03B | $0.06B | 0.41 |
| 2015-06-30 | $0.03B | $0.07B | 0.39 |
| 2015-03-31 | $0.03B | $0.07B | 0.43 |
| 2014-12-31 | $0.03B | $0.07B | 0.43 |
| 2014-09-30 | $0.03B | $-0.01B | -5.37 |
| 2014-06-30 | $0.03B | $0.00B | -7.61 |
| 2014-03-31 | $0.03B | $0.00B | -8.60 |
| 2013-12-31 | $0.04B | $0.00B | 60.06 |
| 2013-09-30 | $0.04B | $0.01B | 6.15 |
| 2013-06-30 | $0.04B | $0.02B | 2.13 |
| 2013-03-31 | $0.03B | $-0.01B | -2.71 |
| 2012-12-31 | $0.03B | $-0.01B | -2.71 |
| 2012-09-30 | $0.02B | $0.00B | 19.67 |
| 2012-06-30 | $0.02B | $0.02B | 1.05 |
| 2012-03-31 | $0.01B | $0.03B | 0.54 |
| 2011-12-31 | $0.01B | $0.02B | 0.75 |
| 2011-09-30 | $0.01B | $0.03B | 0.39 |
| 2011-06-30 | $0.01B | $0.03B | 0.23 |
| 2011-03-31 | $0.01B | $0.03B | 0.20 |
| 2010-12-31 | $0.01B | $0.03B | 0.21 |
| 2010-09-30 | $0.01B | $0.03B | 0.16 |
| 2010-06-30 | $0.01B | $0.03B | 0.19 |
| 2010-03-31 | $0.01B | $0.03B | 0.19 |
| 2009-12-31 | $0.01B | $0.03B | 0.19 |
| 2009-09-30 | $0.01B | $0.01B | 0.80 |
| 2009-06-30 | $0.01B | $0.01B | 0.67 |
| 2009-03-31 | $0.01B | $0.01B | 0.51 |
| 2008-12-31 | $0.01B | $0.01B | 0.60 |
| 2008-09-30 | $0.01B | $0.01B | 0.47 |
| 2008-06-30 | $0.01B | $0.02B | 0.32 |
| 2008-03-31 | $0.01B | $0.02B | 0.29 |
| 2007-12-31 | $0.01B | $0.02B | 0.27 |
| 2007-09-30 | $0.01B | $0.01B | 0.99 |
| 2007-06-30 | $0.01B | $0.01B | 0.93 |
| 2007-03-31 | $0.01B | $0.01B | 0.78 |
| 2006-12-31 | $0.01B | $0.01B | 0.57 |
| 2006-09-30 | $0.00B | 0.00 | |
| 2006-06-30 | $0.00B | 0.00 | |
| 2006-03-31 | $0.00B | 0.00 | |
| 2002-06-30 | $0.00B | $0.00B | 1.22 |
| 2002-03-31 | $0.00B | $0.00B | 1.28 |
| 2001-12-31 | $0.00B | $0.00B | 1.33 |
| 2001-09-30 | $0.00B | $0.00B | 0.87 |
| 2001-06-30 | $0.00B | $0.00B | 0.51 |
| 2001-03-31 | $0.00B | $0.00B | 0.54 |
| 2000-12-31 | $0.00B | $0.00B | 0.42 |
| 2000-09-30 | $0.00B | $0.00B | 0.40 |
| 2000-06-30 | $0.00B | $0.00B | 0.26 |
| 2000-03-31 | $0.00B | $0.00B | 0.21 |
| 1999-12-31 | $0.00B | $0.00B | 0.24 |
| 1999-09-30 | $0.00B | $0.00B | 0.17 |
| 1999-06-30 | $0.00B | $0.00B | 0.15 |
| 1999-03-31 | $0.00B | $0.00B | 0.16 |
| 1998-12-31 | $0.00B | $0.01B | 0.15 |
| 1998-09-30 | $0.00B | $0.01B | 0.12 |
| 1998-06-30 | $0.00B | $0.01B | 0.11 |
| 1998-03-31 | $0.00B | $0.01B | 0.09 |
| 1997-12-31 | $0.00B | $0.00B | 1.01 |
| 1997-09-30 | $0.00B | $0.00B | 1.50 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.042B | $0.101B |
| Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.139B | 14.81 |
| Haemonetics (HAE) | United States | $2.758B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |